Keeping Track Of US FDA Decisions: COVID-Induced Complete Response Letter For Contepo; Safety Sinks Abicipar Pegol; Approvals For Fintepla and Gimoti
Executive Summary
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.